PREGNANCY: Adverse effects were not observed in animal studies, as LMWHs do not cross the placenta. LMWHs are preferred over unfractionated heparin and warfarin (Coumadin) in women who are pregnant. Agents should be discontinued at least 24 hours before planned delivery.
NURSING MOTHERS: Dalteparin enters breast milk, though oral absorption by the infant is extremely low. The effect of this low level of exposure on the infant is unknown.
Medically reviewed by Eni Williams, PharmD
REFERENCE: FDA Prescribing Information.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.